It is not enough to rely on ALT alone as an indicator to assess the necessity of HBV therapy, as hepatitis attacks may be accompanied by changes in several clinical indicators, such as HBsAg, HBV DNA, alpha fetoprotein (AFP), etc (17, 18). The gene discussed is GPT; the disease is hepatitis A virus infection.